News

The ImmunoLogik wishes a merry Christmas and a happy New Year 2019

The ImmunoLogik wishes all people involved in the project, partners and supporters a merry Christmas and a happy New Year 2019.

We are grateful for the support received and various engagement from countless companions in 2019. This gives us confidence to continue resolutely and with full vigor on the chosen path in future.

Read More

Cooperation contract with university hospital Erlangen extended

The ImmunoLogik and the university hospital Erlangen decided to continue their successful cooperation and agreed on an extension of the cooperation contract until September 2019.

The cooperation was and is still an important building block for the development of the innovative lead candidate IML-106 for the efficient and essential treatment of HIV patients who have exploited all available means of the modern therapy and would die due to the unavoidable outbreak of AIDS.

Read More

ImmunoLogik appears on TV science documentary

On Thursday September 13th at prime-time 8.15 p.m. the ImmunoLogik represented by Dr. Christian Setz appears on the German television broadcaster 3sat in the science documentary: Medical research on the move.

The documentary examines alternatives forms of funding of pharmaceutical developments. As one of the presented projects, Christian Setz shares his experiences with crowdfunding as he experienced it with ImmunoLogik.

Read More

Crowdfunding campaign successful

On Sunday May 13th, the ImmunoLogik team around the CEO Dr. Christian Setz and the scientific advisor Prof. Dr. Ulrich Schubert successfully finsihed their crowdinvesting campaign on aescuvest.

More than 200 investors decided to invest together over 300.000 € in the innovative development of the lead candidate IML-106 for the efficient and essential treatment of patients who have exploited all available means of the modern therapy, and who would die due to the unavoidable outbreak of AIDS.

Read More

Start of the Crowdinvesting campaign

On Sunday November 26th, the ImmunoLogik team around the CEO Dr. Christian Setz and the scientific advisor Prof. Dr. Ulrich Schubert started their crowdinvesting campaign on aescuvest. Only there you have the chance to invest and participate in the innovative development of the lead candidate IML-106 for the efficient and essential treatment of patients who have exploited all available means of the modern therapy, and who would die due to the unavoidable outbreak of AIDS.

Read More

Crowdinvesting campaign on aescuvest

The highly qualified ImmunoLogik Team around Dr. Christian Setz (CEO, formerly project leader for HIV-1 at the Institute for Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nuremberg) and the scientific advisor Prof. Dr. Ulrich Schubert (Professor for virology at the Institute for Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nuremberg) will present this funding project on aescuvest in fall 2017. Only here you have the chance to learn more about the concept, to use the information advantage and to become an investor.

Read More